Topic: How To Invest

Q: Dear Pat: I am a relatively new member of your inner circle and would like your opinion on a company that trades in the U.S.: EKSO Bionics Holdings. Thank you.

Article Excerpt

A: Ekso Bionics, $4.66, symbol EKSO on Nasdaq (Shares outstanding: 20.1 million; Market cap: $93.7 million; www.eksobionics.com), develops ready-to-wear, battery-powered exoskeletons. Those modern-day suits of armour aim to improve the strength, mobility and endurance of the wearer. The company’s products are used by the medical, industrial and defense industries. Ekso first began developing its exoskeleton technology in 2005. In 2012, the company introduced it to the rehabilitation community after bringing it to the market as the first robotic exoskeleton. The Ekso GT is intended to help stroke victims and those with spinal cord injuries learn how to walk again. Approved by the Food and Drug Administration in April 2016, the Ekso GT targets an annual market of 268,350 new stroke and spinal cord injuries. The company has now sold or rented out a total of 190 Ekso GTs. Ekso’s products hold conceptual and speculative appeal, but the company had revenue of just $1.5 million for the three months ended June 30, 2016. It…